BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32966868)

  • 1. Visible and near-infrared hyperspectral imaging techniques allow the reliable quantification of prognostic markers in lymphomas: A pilot study using the Ki67 proliferation index as an example.
    Willenbacher E; Brunner A; Willenbacher W; Zelger B; Wolf D; Rogge D; Tappert M; Pallua JD
    Exp Hematol; 2020 Nov; 91():55-64. PubMed ID: 32966868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visible- and near-infrared hyperspectral imaging for the quantitative analysis of PD-L1+ cells in human lymphomas: Comparison with fluorescent multiplex immunohistochemistry.
    Brunner A; Willenbacher E; Willenbacher W; Zelger B; Zelger P; Huck CW; Pallua JD
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121940. PubMed ID: 36208576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visible and Near-Infrared hyperspectral imaging (HSI) can reliably quantify CD3 and CD45 positive inflammatory cells in myocarditis: Pilot study on formalin-fixed paraffin-embedded specimens from myocard obtained during autopsy.
    Brunner A; Schmidt VM; Zelger B; Woess C; Arora R; Zelger P; Huck CW; Pallua J
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jun; 274():121092. PubMed ID: 35257987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
    Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
    Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
    Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
    PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation Activity in Canine Gastrointestinal Lymphoma.
    Wolfesberger B; Burger S; Kummer S; Walter I; Tichy A; Klinger S; Alton K; Burgener IA; Liehmann L; Hammer SE; Rütgen BC; Fuchs-Baumgartinger A
    J Comp Pathol; 2021 Nov; 189():77-87. PubMed ID: 34886989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantification of chemical constituents in matcha with visible-near infrared hyperspectral imaging technology.
    Ouyang Q; Wang L; Park B; Kang R; Chen Q
    Food Chem; 2021 Jul; 350():129141. PubMed ID: 33618087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-Hodgkin lymphomas. Clinical and pathological correlation].
    Becker H
    Fortschr Med; 1981 Jan; 99(1-2):3-8. PubMed ID: 7009354
    [No Abstract]   [Full Text] [Related]  

  • 12. Grading follicular lymphoma on fine needle aspiration specimens. Comparison with proliferative index by DNA image analysis and Ki-67 labeling index.
    Sun W; Caraway NP; Zhang HZ; Khanna A; Payne LG; Katz RL
    Acta Cytol; 2004; 48(2):119-26. PubMed ID: 15085740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.
    Novelli S; Briones J; Flotats A; Sierra J
    Adv Clin Exp Med; 2015; 24(2):325-30. PubMed ID: 25931367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
    Shi YF; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.
    Laurinavicius A; Plancoulaine B; Rasmusson A; Besusparis J; Augulis R; Meskauskas R; Herlin P; Laurinaviciene A; Abdelhadi Muftah AA; Miligy I; Aleskandarany M; Rakha EA; Green AR; Ellis IO
    Virchows Arch; 2016 Apr; 468(4):493-502. PubMed ID: 26818835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical double nuclear staining for cell-specific automated quantification of the proliferation index - A promising diagnostic aid for melanocytic lesions.
    Brogård MB; Nielsen PS; Christensen KB; Georgsen JB; Wandler A; Lade-Keller J; Steiniche T
    Pathol Res Pract; 2024 Mar; 255():155177. PubMed ID: 38330618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic index.
    El Amine O; Ouni R; Adouni O; Goucha A; Ben Hassouna J; Rahal K; El May A; Gamoudi A
    Tunis Med; 2016 Oct; 94(8-9):587-593. PubMed ID: 28685793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive lobular carcinoma of the breast: assessment of proliferative activity using automated Ki-67 immunostaining.
    Dessauvagie B; Thomas A; Thomas C; Robinson C; Combrink M; Budhavaram V; Kunjuraman B; Meehan K; Sterrett G; Harvey J
    Pathology; 2019 Dec; 51(7):681-687. PubMed ID: 31630876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic index.
    El Amine O; Ouni R; Adouni O; Goucha A; Ben Hassouna J; Rahal K; El May A; Gamoudi A
    Tunis Med; 2016 Oct; 94(10):587-593. PubMed ID: 28972249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.